Emily Botto

Amid CVS’ surprise exit from the clinical research space and the ensuing broader questions, study investigates the benefits of pharmacy chain involvement—along with the concerns and barriers to adoption.

First-of-its-kind consortium dedicated to accelerating new medicines development through optimizing patient advocacy group—industry collaboration.

Tufts CSDD study finds that acts of microaggression negatively impact psychological safety and performance.

Tufts CSDD study addresses barriers in recruitment.

2020 Tufts CSDD study examines relationship between investigative site personnel diversity and study participant diversity.

26 interviews conducted by Tufts CSDD found that gender-based microaggressions can negatively impact collaboration and affect retention of women employees.

Improving receptivity and response to the evolving nature of clinical trial patient oversight.